Long Bridge Medical, Inc. — SEC Form D Filing

Long Bridge Medical, Inc. filed an SEC Form D on August 13, 2026, reporting $2.54M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
August 13, 2026
Amount reported
$2.54M
Industry
Medical Devices
Website
https://longbridgemedical.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Patients with inadequate capsular support in their eyes, who are also poor candidates for an Anterior Chamber IOL (ACIOL), lack a standardized way to achieve stable and centered positioning of intraocular lenses.

Solution

Long Bridge Medical is developing the LensOne™ platform, a prosthetic capsular bag designed to restore capsular support and provide stable, centered positioning for intraocular lenses.

Verdict

Investors backed this company on the promise of a novel medical device addressing a complex surgical challenge in ophthalmology, implicitly betting on the team's ability to navigate clinical trials and regulatory hurdles with a physically differentiated product. This cleared because the reported problem's severity and lack of alternatives justified development risk, not because the market's commercialization path was well-defined or easily accessible. The upside was limited by the long development cycles and the immediate need for a robust clinical validation that would satisfy conservative medical device adoption cycles.

Source: SEC EDGAR Form D filing